Life-Saving Cancer Treatment Under Threat as Appeal Challenges NHS Decision
A formal appeal has been lodged after NICE withdrew access to Tecartus, a pioneering CAR-T cancer therapy, from NHS services in England and Wales. Learn why this decision matters for patients with rare lymphoma.

